AtriCure Statistics
Total Valuation
AtriCure has a market cap or net worth of $1.56 billion. The enterprise value is $1.54 billion.
Important Dates
The next estimated earnings date is Tuesday, July 29, 2025, after market close.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AtriCure has 49.50 million shares outstanding. The number of shares has increased by 1.45% in one year.
| Current Share Class | 49.50M |
| Shares Outstanding | 49.50M |
| Shares Change (YoY) | +1.45% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 3.59% |
| Owned by Institutions (%) | 103.26% |
| Float | 47.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.20 |
| Forward PS | 2.85 |
| PB Ratio | 3.55 |
| P/TBV Ratio | 9.45 |
| P/FCF Ratio | 138.10 |
| P/OCF Ratio | 70.49 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 136.11 |
Financial Position
The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.17.
| Current Ratio | 4.11 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | 6.83 |
| Interest Coverage | -5.70 |
Financial Efficiency
Return on equity (ROE) is -8.38% and return on invested capital (ROIC) is -4.12%.
| Return on Equity (ROE) | -8.38% |
| Return on Assets (ROA) | -3.70% |
| Return on Invested Capital (ROIC) | -4.12% |
| Return on Capital Employed (ROCE) | -6.61% |
| Revenue Per Employee | $369,289 |
| Profits Per Employee | -$29,366 |
| Employee Count | 1,300 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.65 |
Taxes
In the past 12 months, AtriCure has paid $1.08 million in taxes.
| Income Tax | 1.08M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +58.96% in the last 52 weeks. The beta is 1.60, so AtriCure's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | +58.96% |
| 50-Day Moving Average | 32.51 |
| 200-Day Moving Average | 33.27 |
| Relative Strength Index (RSI) | 41.36 |
| Average Volume (20 Days) | 477,049 |
Short Selling Information
The latest short interest is 1.83 million, so 3.70% of the outstanding shares have been sold short.
| Short Interest | 1.83M |
| Short Previous Month | 1.56M |
| Short % of Shares Out | 3.70% |
| Short % of Float | 3.83% |
| Short Ratio (days to cover) | 2.61 |
Income Statement
In the last 12 months, AtriCure had revenue of $480.08 million and -$38.18 million in losses. Loss per share was -$0.81.
| Revenue | 480.08M |
| Gross Profit | 358.88M |
| Operating Income | -35.05M |
| Pretax Income | -39.27M |
| Net Income | -38.18M |
| EBITDA | -15.69M |
| EBIT | -35.05M |
| Loss Per Share | -$0.81 |
Full Income StatementBalance Sheet
The company has $99.89 million in cash and $77.41 million in debt, giving a net cash position of $22.47 million or $0.45 per share.
| Cash & Cash Equivalents | 99.89M |
| Total Debt | 77.41M |
| Net Cash | 22.47M |
| Net Cash Per Share | $0.45 |
| Equity (Book Value) | 454.62M |
| Book Value Per Share | 9.19 |
| Working Capital | 190.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $22.19 million and capital expenditures -$10.87 million, giving a free cash flow of $11.33 million.
| Operating Cash Flow | 22.19M |
| Capital Expenditures | -10.87M |
| Free Cash Flow | 11.33M |
| FCF Per Share | $0.23 |
Full Cash Flow StatementMargins
Gross margin is 74.76%, with operating and profit margins of -7.30% and -7.95%.
| Gross Margin | 74.76% |
| Operating Margin | -7.30% |
| Pretax Margin | -7.73% |
| Profit Margin | -7.95% |
| EBITDA Margin | -3.27% |
| EBIT Margin | -7.30% |
| FCF Margin | 2.36% |
Dividends & Yields
AtriCure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.44% |
| Shareholder Yield | -1.44% |
| Earnings Yield | -2.44% |
| FCF Yield | 0.72% |
Dividend DetailsAnalyst Forecast
The average price target for AtriCure is $49.60, which is 57.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $49.60 |
| Price Target Difference | 57.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 13.48% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AtriCure has an Altman Z-Score of 6.25 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.25 |
| Piotroski F-Score | 4 |